Data Bytes: COVID-19 pipeline growth begins to slow down

BioCentury is providing this content for free given the urgent need for information about the coronavirus crisis. Further analysis can be found in our COVID-19 Resource Center. For more, sign up for our daily email.

Sixteen COVID-19 countermeasures entered the pipeline this week, down from 25 entrants last week. BioCentury’s COVID-19 Resource Center is now tracking 640 preclinical and clinical COVID-19 vaccines and therapeutics.

Studies expected to start this week include a master protocol trial launched by the NIH-led ACTIV consortium testing three immunomodulators (see “ACTIV Coming into Focus”).

How to gain access

Continue reading with a
two-week free trial.